Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis, a Controlled and Randomized Trial

NCT02254655 is registered in ClinicalTrials.gov with Chengdu PLA General Hospital as lead sponsor.

NCT NCT02254655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02254655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis, a Controlled and Randomized Trial
Lead sponsor
Chengdu PLA General Hospital
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2013
Completion date
November 30, 2017
Enrollment
119 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis